Chronic Obstructive Pulmonary Disease, or COPD, is a serious condition that affects the lungs, making it hard to breathe. It develops slowly over time and is often caused by damage to the airways and ...

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

For patients with severely compromised lung function, an important treatment is supplemental oxygen. Flawed Medicare payment ...

Patients with COPD who have mucus plugs identified via CT scans are associated with greater risks for acute exacerbations of their disease.

A dipstick urine test and a mobile app may help predict disease exacerbations in COPD patients as much as a week in advance, ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study ...

PORTLAND, OR, UNITED STATES, December 9, 2024 /EINPresswire / -- The global pulmonary drug delivery systems market is experiencing significant growth, driven by various factors including the rising ...